Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Journal of Medical Genetics|June 25, 2020
Sporadic vestibular schwannoma: a molecular testing summaryKatherine V Sadler, Naomi L Bowers, Claire Hartley, et al.Nature Communications|March 27, 2025
Spatial mapping of immune cell environments in NF2-related schwannomatosis vestibular schwannomaAdam P Jones, Michael J Haley, Miriam H Meadows, et al.Neuro-Oncology|December 18, 2020
Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institutionClaire Forde, Andrew T King, Scott A Rutherford, et al.Brain : a Journal of Neurology|December 22, 2022
Genome-wide association analysis identifies a susceptibility locus for sporadic vestibular schwannoma at 9p21Katherine V Sadler, John Bowes, Charlie F Rowlands, et al.Journal of Neurosurgery|May 30, 2020
The microenvironment in sporadic and neurofibromatosis type II-related vestibular schwannoma: the same tumor or different? A comparative imaging and neuropathology studyDaniel Lewis, Carmine A Donofrio, Claire O'Leary, et al.Journal of Medical Genetics|June 26, 2024
<i>NF2</i>-related schwannomatosis and other schwannomatosis: an updated genetic and epidemiological studyClaire Forde, Miriam J Smith, George J Burghel, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 18, 2018
Schwannomatosis: a genetic and epidemiological studyD Gareth Evans, Naomi L Bowers, Simon Tobi, et al.Journal of Medical Genetics|August 29, 2024
Genetic findings in people with schwannomas who do not meet clinical diagnostic criteria for <i>NF2</i>-related schwannomatosisMiriam J Smith, Cristina Perez-Becerril, Mwee van der Meer, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 8, 2018
Identifying the deficiencies of current diagnostic criteria for neurofibromatosis 2 using databases of 2777 individuals with molecular testingD Gareth Evans, Andrew T King, Naomi L Bowers, et al.Acta Neurochirurgica|January 18, 2022
Long-term oncological outcomes after haemorrhagic apoplexy in pituitary adenoma managed operatively and non-operativelyKarol P Budohoski, Sogha Khawari, Andrea Cavalli, et al.Pageof 6